Vanguard Global Advisers »

Sutro Biopharma shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $179k 7.2k 24.91

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Sutro Biopharma

BVF
Samsara BioCapital
Kynam Capital Management
OrbiMed Advisors
Affinity Asset Advisors
Vanguard Capital Management
RA Capital Management
Perceptive Advisors
Point72 Asset Management
ADAR1 Capital Management
Balyasny Asset Management
Woodline Partners
UBS Group
Vanguard Group
Acadian Asset Management

View all funds holding Sutro Biopharma